Developmental and reproductive toxicology

Developmental and reproductive toxicology

Pharmaceuticals and chemicals have sometimes unanticipated and complex impacts on reproductive capacity and/or embryonic development: they can affect sexual function and fertility in adult males and females or lead to malformations, developmental retardations or mortality of the fetus when pregnant women are exposed. Over the past 30 years, fundamental understanding of embryogenesis and mechanisms of developmental toxicity have greatly advanced as well as the regulatory framework of the developmental and reproductive toxicology (DART) studies.

ERBC’ scientists have extensive experience in DART conducting a broad range of ICH and OECD-based studies in rodents and rabbits as well as advanced investigations in rats. They have implemented a historical control database to ensure accuracy and reproducibility of ERBC test results and develop next generation testing approaches that support the 3R principles.

ICH-based studies

All studies presented below can include toxicokinetic analysis

Fertility – Segment I: fertility and early embryonic development to implantation study

Teratology – Segment II: embryo-fetal development study (preliminary and main study)

Fertility and teratology – Segment I and II: combined study

Pre- and post-natal – Segment III

OECD-based studies

Pre-natal developmental toxicity study (preliminary and main study)

Reproduction/Developmental toxicity screening test: preliminary and main study

Reproduction/Developmental toxicity screening test: combined repeated dose toxicity study

One-generation reproduction toxicity study

Two-generation reproduction toxicity study

Extended one-generation reproductive toxicity study

Additional studies

Uterotrophic assay in immature female

Neurotoxicity study in pregnant female and developmental neurotoxicity study